Jiutian Chemical Group - CGS-CIMB Research 2021-02-24: Near-Term Outlook Remains Positive

JIUTIAN CHEMICAL GROUP LIMITED (SGX:C8R) | SGinvestors.io JIUTIAN CHEMICAL GROUP LIMITED (SGX:C8R)

Jiutian Chemical Group - Near-Term Outlook Remains Positive

  • Jiutian Chemical’s FY20 core net profit of RMB155m was below our expectations (78% of our full-year forecast) mainly due to lower-than-expected gross profit margin in 4Q20.
  • We remain positive as near-term ASP outlook remains strong. As of 18 Feb, dimethylformamide (DMF) prices in Southern China stood at RMB10,200 (+25% year-to-date, +82% y-o-y).
  • Maintain ADD with a lower target price of S$0.135 (pegged to 5.7x FY22F P/E).



Juitian Chemical's 4Q20 results below expectations

  • Boosted by higher ASPs, Jiutian Chemical (SGX:C8R) reported a 4Q20 net profit of RMB86m (+66% q-o-q). FY20 core net profit came in at RMB155m, a reversal over FY19's net loss position.
  • Nevertheless, we deem the set of results as below expectations vs our full-year forecast of RMB200m. The key disappointment was lower-than-expected gross profit margin in 4Q20, attributable to higher raw material costs during the quarter.


Near-term outlook remains positive

  • We remain positive on near-term ASP outlook, as we expect downstream demand to stay robust riding on a recovery of China’s economy, as well as rising demand for methylamine (MA) products from fast-growing sectors including electric vehicle (EV) batteries, semiconductor, pharmaceuticals and animal feeds.
  • As of 18 Feb 2021, the dimethylformamide (DMF) asking price (inclusive of 13% value added tax) in Southern China stood at RMB10,200/ton (+25% year-to-date, +82% y-o-y) according to Oilchem.net, an online platform for energy and chemical information in China.
  • We forecast Jiutian Chemical to report a net profit of RMB222m (+28% y-o-y) in FY21F.


Aggressive capacity expansion plans

  • In view of the favourable operating environment, Jiutian Chemical is in the process of finalising an expansion plan comprising a new 100kt MA plant adjacent to its current production facility, which could raise its MA output by 83%. Upon securing the necessary approvals, we estimate that it could take between 1.5 to 2 years for the new plant to commence operations.
  • We estimate capex requirement to be in the range of RMB250m-300m, which could be funded by Jiutian Chemical’s net cash of RMB110m (as of end-FY20), supplemented by its cash generation in FY21-22F.
  • We have yet to factor in the capacity expansion plan into our forecasts.


Maintain ADD with a lower target price of S$0.135






LIM Siew Khee CGS-CIMB Research | ONG Khang Chuen CFA CGS-CIMB Research | Kenneth TAN CGS-CIMB Research | https://www.cgs-cimb.com 2021-02-24
SGX Stock Analyst Report ADD MAINTAIN ADD 0.135 DOWN 0.145



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......